Signal active
Organization
Contact Information
Overview
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers.
Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
About
Biotechnology, Predictive Analytics, mHealth, Personal Health, Therapeutics
2015
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Biofourmis headquartered in United States, North America, operates in the Biotechnology, Predictive Analytics, mHealth, Personal Health, Therapeutics sector. The company focuses on Biotechnology and has secured $92.7B in funding across 200 round(s). With a team of 251-500 employees, Biofourmis is actively contributing to advancements in Biotechnology. Their latest funding round, Angel Round - Biofourmis, raised $71.1K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
10
1
0
$463.6M
Details
9
Biofourmis has raised a total of $463.6M in funding over 9 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Late Stage Venture | 300.0M | ||
2022 | Late Stage Venture | 20.0M | ||
2016 | Seed | 1.0M | ||
2015 | Seed | 71.1K |
Investors
Biofourmis is funded by 51 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Biofourmis | - | FUNDING ROUND - Biofourmis | 1.0M |
Eden Strategy Institute | - | FUNDING ROUND - Eden Strategy Institute | 1.0M |
Biofourmis | - | FUNDING ROUND - Biofourmis | 71.1K |
Eden Strategy Institute | - | FUNDING ROUND - Eden Strategy Institute | 71.1K |
Recent Activity
There is no recent news or activity for this profile.